Summary
Alnylam Pharmaceuticals, Inc. (ALNY) announced the implementation of its 2009 Annual Incentive Program (the "Plan") through an 8-K filing on February 6, 2009. This program is designed to incentivize employees, including executive officers, through annual cash bonuses tied to the achievement of both individual and corporate performance goals for the fiscal year 2009. The structure of the plan indicates a performance-driven compensation approach, aiming to align employee efforts with the company's strategic objectives. The program outlines specific target bonus opportunities as a percentage of base salary for various roles, with the Chief Executive Officer having the highest target at 50%. Individual awards will be determined by performance against individual objectives, ranging from 0% to 100% of the target opportunity. Furthermore, a corporate performance modifier, ranging from 0% to 100%, will be applied, with a threshold requiring at least 50% of corporate performance for any modifier to be applied. The Compensation Committee retains discretion over final award determinations, with payouts expected in January 2010.
Key Highlights
- 1Alnylam has established a 2009 Annual Incentive Program (Plan) to provide cash bonuses to employees, including executive officers.
- 2Bonuses are contingent on achieving both individual and corporate performance goals for fiscal year 2009.
- 3The CEO has the highest target incentive opportunity at 50% of base salary.
- 4Individual awards can range from 0% to 100% of the participant's target opportunity based on individual performance.
- 5A corporate performance modifier (0% to 100%) will be applied, with a minimum threshold of 50% corporate performance required for any modifier to be considered.
- 6The Compensation Committee has discretion to adjust award amounts.
- 7Any awarded bonuses are scheduled to be paid in January 2010.